1.646.889.1200|info@lifescipublicrelations.com

Novel treatments in pipeline for diabetic eye disease

/, video/Novel treatments in pipeline for diabetic eye disease

Novel treatments in pipeline for diabetic eye disease

Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

By | 2018-12-03T15:41:29-04:00 December 3rd, 2018|News, video|Comments Off on Novel treatments in pipeline for diabetic eye disease

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.